The use of two measures of health-related quality of life in HIV-infected individuals: A cross-sectional comparison

被引:33
作者
Copfer, AE
Ampel, NM
Hughes, TE
Gregor, KJ
Dols, CL
Coons, SJ
Colgan, K
Wu, AW
机构
[1] VET AFFAIRS MED CTR, MED SERV 111, TUCSON, AZ 85723 USA
[2] UNIV ARIZONA, COLL MED, TUCSON, AZ 85721 USA
[3] JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, BALTIMORE, MD 21218 USA
[4] UNIV ARIZONA, COLL PHARM, TUCSON, AZ 85721 USA
关键词
Acquired Immunodeficiency Syndrome; health status; HIV-infection; quality of life; questionnaires;
D O I
10.1007/BF00434750
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Two measures of health-related quality of life in 65 HIV-infected individuals were compared in a cross-sectional design. The Quality of Well-Being Scale (QWB) results in a single score ranging from death to perfect health. The MOS-HIV Health Survey (MOS-HIV, 34-item version) gives scores in 11 dimensions. The QWB score distinguished subjects with AIDS from those who were asymptomatic (p=0.027). For the seven multi-item scales of the MOS-HIV, Cronbach's alpha ranged from 0.85-0.95, indicating good internal consistency reliability. Clinical HIV-infection status was significantly associated with the dimensions of Overall Health (p=0.002), Role Function (p=0.022), Social Function (p=0.037), Energy/Fatigue (p=0.027) and Health Distress (p=0.025). All eleven dimensions of the MOS-HIV were significantly correlated with the QWB score (Spearman's coefficient=0.405-0.670; for all, p<0.01) and the QWB score could be predicted from the MOS-HIV dimension scores using multiple regression. The QWB and the MOS-HIV may be useful in assessing health-related quality of life in patients infected with HIV.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 26 条
  • [1] [Anonymous], 1992, MMWR Recomm Rep, V41, P1
  • [2] [Anonymous], MED DECIS MAK
  • [3] BOZZETTE SA, 1995, JAMA-J AM MED ASSOC, V273, P295, DOI 10.1001/jama.273.4.295
  • [4] THE RELIABILITY AND VALIDITY OF 2 HIV-SPECIFIC HEALTH-RELATED QUALITY-OF-LIFE MEASURES - A PRELIMINARY-ANALYSIS
    BURGESS, A
    DAYER, M
    CATALAN, J
    HAWKINS, D
    GAZZARD, B
    [J]. AIDS, 1993, 7 (07) : 1001 - 1008
  • [5] Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297
  • [6] LONGITUDINAL-STUDY ON THE QUALITY-OF-LIFE OF SYMPTOMATIC HIV-INFECTED PATIENTS IN A TRIAL OF ZIDOVUDINE VERSUS ZIDOVUDINE AND INTERFERON-ALPHA
    DEBOER, JB
    VANDAM, FSAM
    SPRANGERS, MAG
    FRISSEN, PHJ
    LANGE, JMA
    [J]. AIDS, 1993, 7 (07) : 947 - 953
  • [7] THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1
    FAHEY, JL
    TAYLOR, JMG
    DETELS, R
    HOFMANN, B
    MELMED, R
    NISHANIAN, P
    GIORGI, JV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) : 166 - 172
  • [8] QUALITY-OF-LIFE EVALUATION IN A CLINICAL-TRIAL OF ZIDOVUDINE THERAPY IN PATIENTS WITH MILDLY SYMPTOMATIC HIV-INFECTION
    GELBER, RD
    LENDERKING, WR
    COTTON, DJ
    COLE, BF
    FISCHL, MA
    GOLDHIRSCH, A
    TESTA, MA
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 116 (12) : 961 - 966
  • [9] A CONTROLLED TRIAL OF EARLY VERSUS LATE TREATMENT WITH ZIDOVUDINE IN SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - RESULTS OF THE VETERANS AFFAIRS COOPERATIVE STUDY
    HAMILTON, JD
    HARTIGAN, PM
    SIMBERKOFF, MS
    DAY, PL
    DIAMOND, GR
    DICKINSON, GM
    DRUSANO, GL
    EGORIN, MJ
    GEORGE, WL
    GORDIN, FM
    HAWKES, CA
    JENSEN, PC
    KLIMAS, NG
    LABRIOLA, AM
    LAHART, CJ
    OBRIEN, WA
    OSTER, CN
    WEINHOLD, KJ
    WRAY, NP
    ZOLLAPAZNER, SB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (07) : 437 - 443
  • [10] VALIDITY OF A QUALITY OF WELL-BEING SCALE AS AN OUTCOME MEASURE IN CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    KAPLAN, RM
    ATKINS, CJ
    TIMMS, R
    [J]. JOURNAL OF CHRONIC DISEASES, 1984, 37 (02): : 85 - 95